文献速递泌尿生殖腹部MR

PI-RADS v2 提高了前列腺穿刺肿瘤分级准确性:单中心经验

Prostate imaging-reporting and data system version 2 has improved biopsy tumor grade accuracy: a single, tertiary institutional experience.
PubMed 文献 · Abdom Radiol (NY) · 2023-04-26

该单中心回顾性研究纳入1191例经穿刺确诊前列腺癌并接受手术的患者,比较PI-RADSv2发布前(2013年,n=394)与发布5年后(2020年,n=797)穿刺与手术标本肿瘤分级的一致性。2020年穿刺前MRI比例显著提高(80.9% vs 4.9%),穿刺与手术分级一致率从47.2%升至54.5%,低估率从46.3%降至36.4%。多因素分析显示穿刺前MRI与分级一致独立相关(OR=1.486)。

要点

  • 穿刺前MRI比例提高与穿刺分级更准确相关,低估率下降。
  • PI-RADSv2发布后穿刺与手术肿瘤分级一致率从47.2%升至54.5%。
  • 阅片时应关注MRI对穿刺分级低估的潜在改善作用。

核心结论

  • PI-RADSv2发布前后穿刺前MRI比例显著变化,与穿刺肿瘤分级准确性提高(低估减少)相关。

研究设计与样本

  • 单中心回顾性研究,纳入1191例经穿刺确诊前列腺癌并接受手术的患者,2013队列n=394,2020队列n=797,比较穿刺与手术标本最高肿瘤分级。
  • 对在本院同时接受前列腺MRI和穿刺的患者,分析穿刺前MRI比例、年龄、PSA,并用logistic回归分析分级一致的相关因素。

临床应用与阅片要点

  • 前列腺MRI(PI-RADSv2)的术前应用可能帮助减少穿刺对肿瘤分级的低估,阅片和报告中应重视MRI对穿刺靶点的引导价值。

局限性

  • 单中心回顾性设计,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate change in prostate biopsy accuracy regarding tumor grade before and after the release of Prostate Imaging-Reporting and Data System version 2 (PI-RADSv2) in a single tertiary institution.

METHODS: We retrospectively evaluated 1191 patients with biopsy-proven prostate cancer (PCa) who had undergone prostate magnetic resonance imaging (MRI) and surgery before (2013 cohort, n = 394) and 5 years after PI-RADSv2 release (2020 cohort, n = 797). The highest tumor grade of each biopsy and surgical specimen was recorded, respectively. We compared concordant, underestimated, and overestimated biopsy rates regarding tumor grade to surgery between two cohorts, respectively. For patients who underwent both prostate MRI and biopsy at our institution, we investigated proportion of pre-biopsy MRI, age, and prostate-specific antigen of patients, and performed logistic regression to analyze which parameters are associated with concordant biopsy.

RESULTS: Concordant and underestimated biopsy rates were significantly different between two cohorts: Concordance and underestimation rates were 47.2% and 46.3% in 2013 and 54.5% and 36.4% in 2020 (p = .019; p = .003), respectively. Overestimated biopsy rates were similar (p = .993). Proportion of pre-biopsy MRI was significantly higher in 2020 than in 2013 (80.9% versus 4.9%; p < .001), and was independently associated with concordant biopsy results in multivariate analysis (odds ratio = 1.486; 95% confidence interval, 1.057-2.089; p = .022).

CONCLUSIONS: There was a significant change in proportion of pre-biopsy MRI before and after the release of PI-RADSv2 in patients who underwent surgery for PCa. This change appears to have improved biopsy accuracy regarding tumor grade by reducing underestimation.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Park, Kang, Kim, et al. Prostate imaging-reporting and data system version 2 has improved biopsy tumor grade accuracy: a single, tertiary institutional experience. Abdom Radiol (NY). 2023. PMID: 37099184. doi:10.1007/s00261-023-03917-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。